| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
3,789 |
2,303 |
$269K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,027 |
5,579 |
$192K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,584 |
1,582 |
$92K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,668 |
3,346 |
$89K |
| 95024 |
|
911 |
907 |
$68K |
| 95144 |
|
13,330 |
4,957 |
$66K |
| 95117 |
|
7,753 |
2,913 |
$57K |
| 95115 |
|
5,763 |
2,156 |
$48K |
| 99205 |
Prolong outpt/office vis |
347 |
347 |
$26K |
| 94060 |
|
635 |
633 |
$22K |
| 96401 |
|
1,050 |
806 |
$21K |
| 95044 |
|
44 |
44 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
257 |
131 |
$8K |
| 94664 |
|
305 |
303 |
$1K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
105 |
40 |
$229.66 |
| 0004A |
|
20 |
20 |
$120.00 |
| 91300 |
|
24 |
23 |
$0.00 |
| J2357 |
Injection, omalizumab, 5 mg |
72 |
66 |
$0.00 |
| J3590 |
Unclassified biologics |
37 |
26 |
$0.00 |